BackOdyssey Therapeutics Overview

Odyssey Therapeutics Net Tangible Assets

Latest net tangible assets for ODTX: $-520M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$-523.69M

Peer average / median

Loading

Odyssey Therapeutics Net Tangible Assets History

Loading

Odyssey Therapeutics vs. peers: Net Tangible Assets Comparison

Loading

Odyssey Therapeutics Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Odyssey Therapeutics (ODTX) FAQ

The latest net tangible assets for ODTX is $-520M as of March 2026. Investors often review this figure alongside Odyssey Therapeutics's historical trend and sector peers before judging valuation or financial health.

A net tangible assets figure of $-520M for ODTX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ODTX's net tangible assets ($-520M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Odyssey Therapeutics's net tangible assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.